Quantcast

Latest epilepsy Stories

2014-07-31 16:29:24

AZ-002 Phase 2a Study in Patients with Epilepsy Planned for Second Half of 2014 MOUNTAIN VIEW, Calif., July 31, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its pipeline and new product development efforts. In the second half of 2014, Alexza expects to initiate a Phase 2a study of AZ-002 (Staccato(®) alprazolam), which is being developed for the management of patients with acute repetitive seizures. Additionally, Alexza has...

2014-07-30 23:14:01

With the rising popularity of “boutique surgeries” being offered by less qualified specialists, ANS has launched an awareness campaign to educate the community on the importance of choosing a neurosurgeon for an accurate diagnosis and to dismiss the idea that you only go to a neurosurgeon when surgery is needed. Morristown, NJ (PRWEB) July 30, 2014 Stroke Treatment Atlantic NeuroSurgical Specialists continues to be a leader in the war against stroke. In 2012, ANS became the first...

2014-07-28 08:30:11

An Innovative Approach That Puts Clinicians in Charge MAPLE GROVE, Minn., July 28, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that it has launched the Upsher-Smith Galaxy(TM), a new and growing suite of antiepileptic drugs (AEDs) that offers people with epilepsy consistent, affordable and accessible therapies. The current Upsher-Smith Galaxy(TM) Portfolio includes seven frequently prescribed AEDs which represent more than one out of every three...

2014-07-23 12:32:42

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243627/Generalized-Tonic-Clonic-Seizure-Global-Clinical-Trials-Review-H2-2014.htmlGeneralized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014" provides data...

2014-07-23 12:31:49

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Neurostimulation: Technologies and Global Marketshttps://www.reportbuyer.com/product/2070063/Neurostimulation-Technologies-and-Global-Markets.htmlREPORT HIGHLIGHTSThe global neurostimulation devices market is expected to reach $3.8 billion in 2013 and $4.1 billion in 2018, with a compound annual growth rate (CAGR) of 1.5%.This report provides:An overview of the global market for...

2014-07-23 08:31:01

- Brivaracetam is the newest investigational medicine to emerge from UCB's rich late-stage pipeline BRUSSELS, July 23, 2014 /PRNewswire/ -- regulated information -- UCB today announced an important advance in its research and development pipeline with positive topline results from the latest Phase 3 study with brivaracetam. This study was designed to evaluate the efficacy and safety of brivaracetam (100 and 200 mg/day, without titration) compared to placebo, as adjunctive treatment in adult...

2014-07-22 08:30:55

LOS ANGELES, July 22, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) Therapy for the treatment of neurological and neuropsychiatric disorders, today announced that enrollment has begun in a pediatric open label study of external trigeminal nerve stimulation (eTNS) as adjunctive therapy for the treatment of Lennox-Gastaut Syndrome (LGS). The trial is being conducted at...

2014-07-18 23:01:32

Transparency Market Research added a new report "Global Epilepsy Therapeutics Market: Industry Analysis, Size, Share, Growth and Forecast 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/epilepsy-therapeutics-market.html. (PRWEB) July 18, 2014 Epilepsy is a group of long-term neurological disorders that is characterized by recurring seizures. These seizures are episodes that occur when group of nerve cells or neurons in brain sends...

2014-07-17 16:20:33

Attribute to Susan Axelrod, Founding Chair, Citizens United for Research in Epilepsy (CURE) CHICAGO, July 17, 2014 /PRNewswire-USNewswire/ -- "CURE applauds the announcement today from the U.S. Department of Defense - allocating $7.5 million dedicated to epilepsy research - and thanks Senator Dick Durbin (D-IL) for his leadership on this issue. The incidence of epilepsy increased by an alarming 52 percent from 2006 to 2010, with approximately 8 percent of those afflicted having been...

2014-07-16 20:23:07

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability https://www.reportbuyer.com/product/2052296/Epilepsy-Therapeutics-in-Asia-Pacific-Markets-to-2019---Treatment-Options-Enhanced-As-Novel-Next-Generation-AEDs-Show-Improved-Safety-and-Tolerability.html Epilepsy Therapeutics in Asia Pacific...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related